February, months behind the United States and many other countries. Officials blamed a shortage of Pfizer Inc. vaccine from ...
The Trump administration’s dramatic reworking of U.S. public-health agencies’ approach to vaccines is creating a difficult and unpredictable situation for drugmakers. Pfizer, in particular, could be ...
House Republicans subpoenaed Pfizer’s former Vice President and Chief Scientific Officer of RNA and Viral Vaccines Dr. Philip Dormitzer. The House Judiciary Committee requested in May that Dormitzer ...
Parents in the United States who want to vaccinate their young children against Covid-19 may face a growing set of challenges this fall. The US Food and Drug Administration might not renew ...
Vaccine advisers to the US Food and Drug Administration voted 17-0 with one abstention Tuesday to recommend Pfizer's COVID-19 vaccine in children 5 to 11. Members of the FDA's Vaccines and Related ...
Most people won't experience allergic reactions to the vaccine, experts insist. The Food and Drug Administration late Friday authorized Pfizer's COVID-19 vaccine for people ages 16 and up, but warned ...
A vaccine originally designed to protect against Covid-19 has shown unexpected promise in helping the immune system fight ...
Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...
Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus season, the FDA has approved updated shots from Pfizer and Moderna. But ...
(Reuters) -Pfizer and Moderna on Wednesday defended their COVID-19 vaccines as having saved millions of lives worldwide, in separate responses to U.S. President Donald Trump's demand that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results